Selling Stockholders Plan to Sell 28M Shares of Common Stock
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
This filing relates to the offer and sale from time to time by the selling stockholders of up to 28M shares of common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HCTI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HCTI
About HCTI
Healthcare Triangle, Inc. is a healthcare information technology company. The Company is focused on advancing industry transformation in the sectors of cloud services, data science, and professional and managed services for the electronic health record (EHR), healthcare and life sciences industries. The Company operates through three segments: Software Services, Managed Services and Support, and Corporate & others. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its technology platforms include CloudEz, DataEz, Niyama and Readabl.AI platforms. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers in their efforts to improve data management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare Triangle Closes $4.235 Million Private Placement
- Financing Size: Healthcare Triangle, Inc. has completed a private placement of senior convertible promissory notes totaling $4.235 million at a 15% original issue discount, with net proceeds expected to be approximately $3.6 million after deducting placement agent fees, enhancing the company's liquidity.
- Note Terms: The notes mature on December 12, 2026, and can be converted by the holder at any time after six months from the original issue date at a conversion price equal to 85% of the company's common stock VWAP, providing flexible capital structure options that may attract investors.
- Use of Proceeds: The company intends to use the net proceeds from this offering for repayment of certain prior indebtedness, potential strategic acquisitions, and general working capital, indicating a strategic focus on future growth opportunities.
- Underwriter Role: WallachBeth Capital LLC acted as the placement agent for this offering, further solidifying its market position in providing capital market services to the healthcare sector, leveraging its extensive experience in the industry.
See More
Healthcare Triangle Closes $4.235 Million Private Placement
- Financing Size: Healthcare Triangle, Inc. has completed a private placement totaling $4.235 million, with expected net proceeds of approximately $3.6 million to be used for repaying certain debts and potential strategic acquisitions, thereby enhancing the company's financial flexibility.
- Convertible Note Terms: The issued convertible notes come with a 15% original issue discount, allowing holders to convert at a price equal to 85% of the VWAP after six months, providing investors with potential upside as the stock price increases in the future.
- Underwriter Role: WallachBeth Capital LLC acted as the placement agent for this private offering, leveraging its expertise in capital markets to connect Healthcare Triangle with investors, thereby supporting its financing objectives and further solidifying its market position in the healthcare sector.
- Compliance Statement: The notes and the common stock issuable upon conversion have not been registered under the Securities Act, indicating the company's commitment to legal compliance while ensuring investors are aware of associated risks, thus maintaining market transparency.
See More
Healthcare Triangle Completes Private Placement Financing
- Private Placement Completed: Healthcare Triangle (HCTI) announced on Friday the successful closure of its private placement with a 15% original issue discount, indicating the company's strong financing capability in the capital markets, which will support future business expansion.
- Capital Structure Optimization: This financing will help HCTI optimize its capital structure and enhance financial flexibility, thereby providing necessary funding for further investments and innovations in the healthcare sector.
- Market Confidence Boost: The successful private placement sends a positive signal to the market, indicating investor confidence in HCTI's future growth potential, which may have a favorable impact on the company's stock price.
- Strategic Development Support: The completion of this financing provides HCTI with the necessary funding to support its strategic development in healthcare technology and services, expected to accelerate its market penetration and enhance competitiveness in the industry.
See More
Healthcare Triangle Closes $4.235 Million Convertible Note Private Placement
- Financing Size: Healthcare Triangle has completed a private placement of convertible notes totaling $4.235 million, expecting to net approximately $3.6 million for debt repayment and potential strategic acquisitions, thereby enhancing the company's financial flexibility.
- Note Terms: The notes are convertible at a price equal to 85% of the company's common stock VWAP, allowing holders to convert at any time after six months, which may attract more investor interest and increase market visibility.
- Market Compliance: The notes are not registered under securities laws, meaning the company must adhere to strict compliance requirements, which could impact the ease and cost of future financing.
- Industry Position: Healthcare Triangle's leadership in digital transformation solutions, coupled with its HITRUST certification, further solidifies its competitive advantage in the healthcare sector, likely attracting more clients and partnership opportunities.
See More
Healthcare Triangle Closes $4.235 Million Private Placement
- Financing Size: Healthcare Triangle has completed a private placement of $4.235 million in 15% original issue discount senior convertible promissory notes, expecting to net approximately $3.6 million after deducting related fees, with proceeds aimed at repaying certain debts and potential strategic acquisitions.
- Conversion Terms: The notes are convertible at a price equal to 85% of the VWAP of the company's common stock for the three trading days preceding the conversion notice, providing investors with flexibility to convert after six months, which may attract more investor participation.
- Market Impact: This financing will enhance the company's liquidity, supporting its digital transformation strategy in the healthcare and life sciences sectors, and is expected to improve its competitive position and market standing.
- Compliance Statement: The notes and the common stock issuable upon conversion have not been registered under securities laws, indicating the company's commitment to compliance during the financing process, thereby reducing potential legal risks.
See More
Healthcare Triangle Reports Q1 Revenue Growth
- Revenue Performance: Healthcare Triangle reported Q1 revenue of $9.9 million for 2026, marking a significant increase compared to the previous year, reflecting the company's competitive position and business expansion capabilities.
- Gross Profit Improvement: The consolidated gross profit rose from $300,000 in Q1 2025 to $2.4 million in Q1 2026, an increase of approximately $2.1 million, indicating a substantial enhancement in overall profitability.
- Business Contribution: The Teyame and Datono segments contributed $2 million to the gross profit increase, demonstrating the strong unit economics and effective value-added service model of these business units.
- Strategic Implications: This financial performance not only boosts investor confidence but also provides a solid foundation for future expansion and investment decisions, signaling ongoing growth potential.
See More
Healthcare Triangle Closes $4.235 Million Private Placement
- Financing Size: Healthcare Triangle, Inc. has completed a private placement of senior convertible promissory notes totaling $4.235 million at a 15% original issue discount, with net proceeds expected to be approximately $3.6 million after deducting placement agent fees, enhancing the company's liquidity.
- Note Terms: The notes mature on December 12, 2026, and can be converted by the holder at any time after six months from the original issue date at a conversion price equal to 85% of the company's common stock VWAP, providing flexible capital structure options that may attract investors.
- Use of Proceeds: The company intends to use the net proceeds from this offering for repayment of certain prior indebtedness, potential strategic acquisitions, and general working capital, indicating a strategic focus on future growth opportunities.
- Underwriter Role: WallachBeth Capital LLC acted as the placement agent for this offering, further solidifying its market position in providing capital market services to the healthcare sector, leveraging its extensive experience in the industry.
See More
Healthcare Triangle Closes $4.235 Million Private Placement
- Financing Size: Healthcare Triangle, Inc. has completed a private placement totaling $4.235 million, with expected net proceeds of approximately $3.6 million to be used for repaying certain debts and potential strategic acquisitions, thereby enhancing the company's financial flexibility.
- Convertible Note Terms: The issued convertible notes come with a 15% original issue discount, allowing holders to convert at a price equal to 85% of the VWAP after six months, providing investors with potential upside as the stock price increases in the future.
- Underwriter Role: WallachBeth Capital LLC acted as the placement agent for this private offering, leveraging its expertise in capital markets to connect Healthcare Triangle with investors, thereby supporting its financing objectives and further solidifying its market position in the healthcare sector.
- Compliance Statement: The notes and the common stock issuable upon conversion have not been registered under the Securities Act, indicating the company's commitment to legal compliance while ensuring investors are aware of associated risks, thus maintaining market transparency.
See More
Healthcare Triangle Completes Private Placement Financing
- Private Placement Completed: Healthcare Triangle (HCTI) announced on Friday the successful closure of its private placement with a 15% original issue discount, indicating the company's strong financing capability in the capital markets, which will support future business expansion.
- Capital Structure Optimization: This financing will help HCTI optimize its capital structure and enhance financial flexibility, thereby providing necessary funding for further investments and innovations in the healthcare sector.
- Market Confidence Boost: The successful private placement sends a positive signal to the market, indicating investor confidence in HCTI's future growth potential, which may have a favorable impact on the company's stock price.
- Strategic Development Support: The completion of this financing provides HCTI with the necessary funding to support its strategic development in healthcare technology and services, expected to accelerate its market penetration and enhance competitiveness in the industry.
See More
Healthcare Triangle Closes $4.235 Million Convertible Note Private Placement
- Financing Size: Healthcare Triangle has completed a private placement of convertible notes totaling $4.235 million, expecting to net approximately $3.6 million for debt repayment and potential strategic acquisitions, thereby enhancing the company's financial flexibility.
- Note Terms: The notes are convertible at a price equal to 85% of the company's common stock VWAP, allowing holders to convert at any time after six months, which may attract more investor interest and increase market visibility.
- Market Compliance: The notes are not registered under securities laws, meaning the company must adhere to strict compliance requirements, which could impact the ease and cost of future financing.
- Industry Position: Healthcare Triangle's leadership in digital transformation solutions, coupled with its HITRUST certification, further solidifies its competitive advantage in the healthcare sector, likely attracting more clients and partnership opportunities.
See More
Healthcare Triangle Closes $4.235 Million Private Placement
- Financing Size: Healthcare Triangle has completed a private placement of $4.235 million in 15% original issue discount senior convertible promissory notes, expecting to net approximately $3.6 million after deducting related fees, with proceeds aimed at repaying certain debts and potential strategic acquisitions.
- Conversion Terms: The notes are convertible at a price equal to 85% of the VWAP of the company's common stock for the three trading days preceding the conversion notice, providing investors with flexibility to convert after six months, which may attract more investor participation.
- Market Impact: This financing will enhance the company's liquidity, supporting its digital transformation strategy in the healthcare and life sciences sectors, and is expected to improve its competitive position and market standing.
- Compliance Statement: The notes and the common stock issuable upon conversion have not been registered under securities laws, indicating the company's commitment to compliance during the financing process, thereby reducing potential legal risks.
See More
Healthcare Triangle Reports Q1 Revenue Growth
- Revenue Performance: Healthcare Triangle reported Q1 revenue of $9.9 million for 2026, marking a significant increase compared to the previous year, reflecting the company's competitive position and business expansion capabilities.
- Gross Profit Improvement: The consolidated gross profit rose from $300,000 in Q1 2025 to $2.4 million in Q1 2026, an increase of approximately $2.1 million, indicating a substantial enhancement in overall profitability.
- Business Contribution: The Teyame and Datono segments contributed $2 million to the gross profit increase, demonstrating the strong unit economics and effective value-added service model of these business units.
- Strategic Implications: This financial performance not only boosts investor confidence but also provides a solid foundation for future expansion and investment decisions, signaling ongoing growth potential.
See More
